Przegląd Gastroenterologiczny

Abstract

1/2023 vol. 18
Review paper

Gastrointestinal symptoms in COVID-19

Konrad Lewandowski 1
,
Magdalena Kaniewska 1
,
Mariusz Rosołowski 2, 3
,
Grażyna Rydzewska 1, 4
  1. Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Unit, Central Clinical Hospital of Ministry of Inferior and Administration, Warsaw, Poland
  2. Department of Internal Medicine and Hypertension, Medical University of Bialystok, Bialystok, Poland
  3. Department of Hypertension, Gastroenterology, and Internal Medicine, Medical University of Bialystok Clinical Hospital, Bialystok, Poland
  4. Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Gastroenterology Rev 2023; 18 (1): 61–66
DOI: https://doi.org/10.5114/pg.2021.112683
Online publish date: 2022/01/18
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
SARS-CoV-2 infection manifests mainly by involving the respiratory system. Due to the presence of abdominal symptoms, the digestive system is clearly involved in the expression, transmission, and possible pathogenesis of COVID-19. There are many theories regarding the development of abdominal symptoms, including angiotensin 2 receptor, cytokine storm, and disturbances of the intestinal microbiome. This paper provides an overview of the most important meta-analyses and publications on gastrointestinal symptoms and the gut microbiome in COVID-19.

Keywords

SARS-CoV-2, COVID-19, gastrointestinal symptoms, gut microbiota

Share
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
integrated with publons
plagiat pl
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications